ArticleLancet regional health. Americas2026
The burden of oral disorders in Latin America and Caribbean countries from 1990 to 2023 and projections until 2050: a systematic analysis for the Global Burden of Disease Study 2023.
Article in Lancet regional health. Americas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A biomimetic urchin-like photothermal nanoplatform for the efficient eradication ofFrontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral disorders (OD) are the most prevalent non-communicable conditions worldwide. We analyse the burden of OD in Latin America and the Caribbean (LAC) from 1990 to 2023, with projections to 2050. Methods: This analysis used Global Burden of Disease (GBD) 2023 estimates of incidence, prevalence, and years lived with disability (YLDs) for untreated dental caries of deciduous (UDCD) and permanent teeth (UDCP), severe periodontitis, edentulism, and other OD across 33 LAC countries. DisMod-MR 2.1, spatiotemporal regression, and MR-BRT were applied. YLDs were calculated as prevalence multiplied by disability weights. Associations with the Socio-demographic Index (SDI) were assessed using LOWESS smoothers. Forecasts to 2050 incorporated demographic and risk-factor trends. Findings: In 2023, OD in LAC caused 290.8 million (95% UI 259.3-325.4) incident cases, 308.2 million (285.9-332.7) prevalent cases, and 2.41 million (1.51-3.48) YLDs. They ranked first in prevalence, second in incidence, and tenth in YLDs among all causes over the past three decades. UDCD peaked in childhood, UDCP in young adulthood and midlife; while severe periodontitis and edentulism predominated in older adults, with YLDs increasing sharply with age. Higher SDI correlated inversely with edentulism but positively with severe periodontal disability. By 2050, YLDs are projected to reach 3.81 million (2.28-5.80). Interpretation: Despite progress in child oral health, OD remain a leading cause of YLDs in LAC. Integrating oral health into primary care and UHC across the life course, alongside action on upstream social and commercial determinants is essential to reduce the burden. Funding: The GBD2023 Study is supported by the Gates Foundation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.